Cargando…

A Novel Thrombosis-Related Signature for Predicting Survival and Drug Compounds in Glioblastoma

Glioblastoma is the most common primary tumor in the central nervous system, and thrombosis-associated genes are related to its occurrence and progression. Univariate Cox and LASSO regression analysis were utilized to develop a new prognostic signature based on thrombosis-associated genes. Gene onto...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zeng, Wen-Jing, Cao, Yu-Fang, Li, He, Gong, Zhi-Cheng, Wu, Wantao, Luo, Peng, Zhang, Jian, Liu, Zaoqu, Zhang, Hao, Cheng, Quan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9300384/ https://www.ncbi.nlm.nih.gov/pubmed/35874629 http://dx.doi.org/10.1155/2022/6792850

Ejemplares similares

Comprehensive analysis of pyroptosis‐related gene signatures for glioblastoma immune microenvironment and target therapy
por: Wang, Zeyu, et al.
Publicado: (2023)

Pericyte mediates the infiltration, migration, and polarization of macrophages by CD163/MCAM axis in glioblastoma
por: Zhang, Hao, et al.
Publicado: (2022)

Antigen Presentation Machinery Signature-Derived CALR Mediates Migration, Polarization of Macrophages in Glioma and Predicts Immunotherapy Response
por: Chen, Rui, et al.
Publicado: (2022)

Corrigendum: Antigen Presentation Machinery Signature-Derived CALR Mediates Migration, Polarization of Macrophages in Glioma and Predicts Immunotherapy Response
por: Chen, Rui, et al.
Publicado: (2022)

Glioblastoma glycolytic signature predicts unfavorable prognosis, immunological heterogeneity, and ENO1 promotes microglia M2 polarization and cancer cell malignancy
por: Liang, Xisong, et al.
Publicado: (2022)

Identify the immune characteristics and immunotherapy value of CD93 in the pan-cancer based on the public data sets
por: Guo, Aiyuan, et al.
Publicado: (2022)

An artificial intelligence network‐guided signature for predicting outcome and immunotherapy response in lung adenocarcinoma patients based on 26 machine learning algorithms
por: Zhang, Nan, et al.
Publicado: (2023)

Tumor-secreted lactate contributes to an immunosuppressive microenvironment and affects CD8 T-cell infiltration in glioblastoma
por: Wang, Zeyu, et al.
Publicado: (2023)

Identification of a Hypoxia-Angiogenesis lncRNA Signature Participating in Immunosuppression in Gastric Cancer
por: Wang, Zicheng, et al.
Publicado: (2022)

Novel Immune Infiltrating Cell Signature Based on Cell Pair Algorithm Is a Prognostic Marker in Cancer
por: Zhang, Hao, et al.
Publicado: (2021)

Comprehensive development and validation of gene signature for predicting survival in patients with glioblastoma
por: Jin, Yi, et al.
Publicado: (2022)

A Pan-Cancer Analysis Reveals CLEC5A as a Biomarker for Cancer Immunity and Prognosis
por: Chen, Rui, et al.
Publicado: (2022)

Large-Scale Single-Cell and Bulk Sequencing Analyses Reveal the Prognostic Value and Immune Aspects of CD147 in Pan-Cancer
por: Zhang, Jingwei, et al.
Publicado: (2022)

A pan-cancer and single-cell sequencing analysis of CD161, a promising onco-immunological biomarker in tumor microenvironment and immunotherapy
por: Li, He, et al.
Publicado: (2022)

PTX3 mediates the infiltration, migration, and inflammation‐resolving‐polarization of macrophages in glioblastoma
por: Zhang, Hao, et al.
Publicado: (2022)

Network Signatures of Survival in Glioblastoma Multiforme
por: Patel, Vishal N., et al.
Publicado: (2013)

Machine learning-based identification of tumor-infiltrating immune cell-associated lncRNAs for improving outcomes and immunotherapy responses in patients with low-grade glioma
por: Zhang, Nan, et al.
Publicado: (2022)

A Potential Prognostic Gene Signature for Predicting Survival for Glioblastoma Patients
por: Hou, Ziming, et al.
Publicado: (2019)

Define cancer-associated fibroblasts (CAFs) in the tumor microenvironment: new opportunities in cancer immunotherapy and advances in clinical trials
por: Zhang, Hao, et al.
Publicado: (2023)

The Comprehensive Analysis Identified an Autophagy Signature for the Prognosis and the Immunotherapy Efficiency Prediction in Lung Adenocarcinoma
por: Li, Xizhe, et al.
Publicado: (2022)

B Cell Receptor Signaling Pathway Mutation as Prognosis Predictor of Immune Checkpoint Inhibitors in Lung Adenocarcinoma by Bioinformatic Analysis
por: Lin, Anqi, et al.
Publicado: (2022)

Large-scale bulk RNA-seq analysis defines immune evasion mechanism related to mast cell in gliomas
por: Chen, Rui, et al.
Publicado: (2022)

Identify the Prognostic and Immune Profile of VSIR in the Tumor Microenvironment: A Pan-Cancer Analysis
por: Liu, Yuanyuan, et al.
Publicado: (2022)

Hyaluronic acids mediate the infiltration, migration, and M2 polarization of macrophages: evaluating metabolic molecular phenotypes in gliomas
por: Zhang, Hao, et al.
Publicado: (2022)

Pan-Cancer Analysis of the Immunological Role of PDIA5: A Potential Target for Immunotherapy
por: Chen, Yu, et al.
Publicado: (2022)

Immune checkpoint modulators in cancer immunotherapy: recent advances and emerging concepts
por: Wang, Yuchen, et al.
Publicado: (2022)

B2M overexpression correlates with malignancy and immune signatures in human gliomas
por: Zhang, Hao, et al.
Publicado: (2021)

A Six-lncRNA Signature for Immunophenotype Prediction of Glioblastoma Multiforme
por: Gao, Ming, et al.
Publicado: (2021)

Distinguishing Glioblastoma Subtypes by Methylation Signatures
por: Zhang, Yu-Hang, et al.
Publicado: (2020)

A Pyroptosis-Related Gene Signature for Predicting Survival in Glioblastoma
por: Li, Xin-Yu, et al.
Publicado: (2021)

Identification of an IFN-β-associated gene signature for the prediction of overall survival among glioblastoma patients
por: Cheng, Lijing, et al.
Publicado: (2021)

A Novel Six-mRNA Signature Predicts Survival of Patients With Glioblastoma Multiforme
por: Liu, Zhentao, et al.
Publicado: (2021)

Mutations Status of NOTCH Signaling Pathway Predict Prognosis of Immune Checkpoint Inhibitors in Colorectal Cancer
por: Lin, Anqi, et al.
Publicado: (2023)

Overexpression of IGFBP2 mRNA predicts poor survival in patients with glioblastoma
por: Yuan, Qing, et al.
Publicado: (2019)

A Novel Prognostic Signature of Transcription Factors for the Prediction in Patients With GBM
por: Cheng, Quan, et al.
Publicado: (2019)

Transcriptional signatures in histologic structures within glioblastoma tumors may predict personalized drug sensitivity and survival
por: Kersch, Cymon N, et al.
Publicado: (2020)

A 4-miRNA signature to predict survival in glioblastomas
por: Hermansen, Simon K., et al.
Publicado: (2017)

An Immune-Related Gene Pairs Signature for Predicting Survival in Glioblastoma
por: Wang, Sheng, et al.
Publicado: (2021)

Identification of SEC61G as a Novel Prognostic Marker for Predicting Survival and Response to Therapies in Patients with Glioblastoma
por: Liu, Bo, et al.
Publicado: (2019)

Clinical Significance and Immune Landscape of a Pyroptosis-Derived LncRNA Signature for Glioblastoma
por: Xing, Zhe, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_agqusjqbqm69v2d2gcunfqklo0